Lyra Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Lyra Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Lyra Therapeutics Inc
Rating: 1.12766675
Author: Trendlyne DVM scores

about

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business...

6.50 -0.08 (-1.22%)

82.67% Fall from 52W High

3,534

XNAS Volume

XNAS 10 Sep, 2025 11:24 AM (EDT)

Not Eligible

Expensive Valuation

9.2 / 100

Technically Neutral

35.9 / 100

1Yr Price target upside is 77%

2 analysts

Lyra Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lyra Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business...

82.67% Fall from 52W High

SWOT Analysis

Lyra Therapeutics Inc Live Price Chart